To view this email as a web page, click here.
October 18, 2018
 
Treatments for Actinic Keratosis
 
Topical 5-fluorouracial still may be the best bet in actinic keratoses
Topical 5-fluorouracial (5-FU), which is FDA approved for treating actinic keratoses and superficial basal cell carcinoma, shows the strongest evidence of effectiveness for these two conditions plus squamous cell carcinoma, according to a comprehensive systematic review.
 
A two-system procedure for clearing actinic keratoses
Study finds daylight photodynamic therapy with ablative fractional laser more effective than with microdermabrasion for treating actinic keratoses with large area field cancerization.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.